We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.


Clear all

Refine your search

Content type



22 results found


Fox Rothschild LLP | USA | 13 Feb 2013

FDA seeks public comment on questions related to drug and biological product shortages

Pursuant to the Food and Drug Administration Safety and Innovation Act (FDASIA) signed into law on July 9, 2012, the Food and Drug Administration


Fox Rothschild LLP | USA | 30 Jan 2013

State's "more stringent" Stark Law restrictions upheld by court

Today I am focusing on the self-referral ban under the federal Stark laws. In particular, a recent case - Fresenius Medical Care Holdings, Inc. v


Fox Rothschild LLP | USA | 18 Jan 2013

Green groups clash with business over NJ enviro waivers

A New Jersey appellate court is set to determine the fate of a controversial measure by the state's environmental regulator to waive land use


Fox Rothschild LLP | USA | 3 Jan 2013

OIG announces 2013 priorities

Now that the new year is upon us, today's post will look at the Department of Health and Human Services' Office of Inspector General (OIG), in particular


Fox Rothschild LLP | USA | 28 Dec 2012

Encouraging in-house disclosures in a whistleblower's world

Compliance officials have a great deal to worry about. They are judged by results and loaded with stress over the latest changes in government guidance


Fox Rothschild LLP | USA | 2 Oct 2012

Government suggests drug coupons do not violate the anti-kickback law

Today, I was intrigued by a Washington Post article about branded drug companies offering discount coupons to stave off competition from generic drug manufacturers.


Fox Rothschild LLP | USA | 8 Aug 2012

Bad actors continue to pay

Recent press releases provide notice of activities that draw the government's ire -- and result in serious criminal consequences.


Fox Rothschild LLP | USA | 14 Jun 2012

Court ruling broadens hospital exposure to whistleblower claims for teaching physician Medicare billing

The 7th Circuit Court of Appeals recently issued a decision of interest to physicians and teaching hospitals. It concerns the method of rotating teaching physicians between multiple surgeries and billing Medicare for those services.


Fox Rothschild LLP | USA | 9 Apr 2012

OIG alert encourages physicians to use care when reassigning Medicare payments

Physicians who reassign their right to bill the Medicare program can still be liable for false claims submitted by the entities who obtained that reassignment, as discussed in a recent "Alert" issued by the Office of Inspector General (OIG).


Fox Rothschild LLP | USA | 2 Apr 2012

Will the threat of personal liability stifle corporate activity?

Both the federal Food and Drug Administration (FDA) and Office of the Inspector General (OIG) have authority to seek personal consequences against corporate officers deemed responsible for federal health care violations.

Previous page 1 2 3